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Objective.Geneticheterogeneityandriskfactordistributionwasanalyzedintwopreviouslyproposedasthmaphenotypes.Method.
A sample of 412 subjects was investigated at 7-8, 12-13, and 21-22 years of age with questionnaires, skin prick tests, and genetic
analysis of IL-4 receptor (IL4R) single-nucleotide polymorphisms. The sample was subdivided in one group with no asthma, and
two groups with asthma separated by age of onset of symptoms, namely, early onset asthma (EOA) and late onset asthma (LOA).
Risk factors and IL4R markers were analyzed in respect to asthma phenotypes. Results. EOA and LOA groups were both associated
withatopyandamaternalhistoryofasthma.FemalegenderwasmorecommoninLOA,whereaschildhoodeczema,frequentcolds
in infancy, and a paternal history of asthma were more common in EOA. The AA genotype of rs2057768 and the GG genotype of
rs1805010 were more common in LOA, whereas the GG genotype of rs2107356 was less common in EOA. Conclusion. Our data
suggest that early and late onset asthma may be of diﬀerent endotypes and genotypes.
1.Introduction
Asthma is a common disease, but it has been questioned
if it is one single disease, or a group of asthmatic diseases.
Such diﬀerent “phenotypes” of asthma may vary in response
to treatment [1], in prognosis [2], in inﬂammatory patterns
[3], and in susceptibility to environmental exposure [4].
Identifying possible subphenotypes has therefore rendered
increasing interest in recent years [5, 6]. But a reliable
subgroup classiﬁcation of asthma (or any other disease)
can seldom include only clinical parameters, very often
additionalbiomarkershavetobeincluded[7]inordertoﬁnd
genetic or endotypic diﬀerences.
In the 1990s, the Tucson group presented data on lung
function of infants from a population-based birth-cohort
study and they also retrospectively classiﬁed preschool
wheeze into three subgroups or phenotypes, namely, tran-
sient wheeze, early persistent wheeze, and late onset asthma
[8]. Interestingly, not only transient wheeze had a char-
acteristic phenotype pattern, there were also diﬀerences
between the two asthma subgroups, with eczema being more
common among children with early persistent wheeze than
among children with asthma onset after the age of 3 years. If
thenoticeddiﬀerenceintheprevalenceofeczemainchildren
with early versus late onset of respiratory symptoms is of any
phenotypic signiﬁcance is, however, not known. Our own
data reveal that 12-13-year-old children with asthma and
eczema diﬀer regarding the interleukin-4 receptor genotype
from children with asthma, but with no eczema [9]. On the
other hand, we have also seen that the same genetic pattern
in children may have diﬀerent consequences in adult women
with severe atopic asthma [10]. If these contrasting results
are due to diﬀerent asthma phenotypes being tested, or to
random associations in diﬀerent studies, is still not known.
However, since the association between asthma and eczema
resembles the phenotype “early persistent wheeze” used in2 Journal of Allergy
the Tucson study, and there is a predominance of females
among adults with asthma, we wanted to investigate if
early onset asthma (<3 years) has phenotypic and genotypic
diﬀerences as compared to asthma starting at an older age.
The aim of the present study was to apply, as close
as possible, the Tucson-based phenotypes “early persistent
wheeze” and “late onset asthma” on a cohort of children,
followed from 7-8 to 21-22 years of age, in order to test if
these “phenotypes” have diﬀerent patterns in inherent risk
factors for asthma, in asthma-associated features, and in
genetic markers from the IL-4-receptor.
2. Methods
2.1. Subjects. A cross-sectional questionnaire study was
performed in 1991, covering all 7–9-year-old children in
Kiruna, a town in the northernmost part of Sweden, and
a selected sample of 7-year-old children in Gothenburg, a
city on the south-west coast of Sweden. In Gothenburg we
choose a sample of schools covering known variations in
socioeconomy and in environmental pollution. The cohort
comprised 2481 children. A stratiﬁed subsample of 412 7-
8-year-old children were chosen for further interviews and
allergy testing in 1992. In 1996, when the children had
reached 12-13 years of age, they were once again contacted
for a followup. 402 children accepted to take part in the fol-
lowup, which included a questionnaire, an interview, allergy
testing, and blood sampling. The recruiting procedure, the
power calculations, and the stratiﬁcation procedure have
previouslybeendescribedindetail[11,12].In2005,asecond
questionnaire followup was performed. Two hundred and
eighty-four subjects, with an age of 21-22 years, agreed to
participate; 152 women and 132 men. Of those who in 2005
accepted to participate, 35 (12.3%) reported current asthma
at 12-13 years of age. The corresponding ﬁgure for the 118
missing subjects was 15 (12.7%), (P = 0.915, Chi-square).
A ﬂow chart of the recruiting and follow-up procedure is
presented in Figure 1.
The questions about current and former disease in the
followup were similar as in the original cross-sectional study
from 1991 [11]; as to asthma and eczema we asked: have
you/your child ever had asthma or asthmatic bronchitis?
Have you/your child ever had eczema? Have there been any
symptoms in the last year?
From retrospective questionnaire data at 7 years of age,
we collected information on symptoms and disease during
the preschool years, as well as information on age when
symptoms of disease were ﬁrst noted, the number of colds
the child had during the ﬁrst year of life, and if there was
a parental history of asthma. Data on current asthma and
eczema, that is symptoms within the last 12 months, were
collected at 7-8 years, 12-13 years, and 21-22 years of age.
2.2. Allergy Testing. Allergy testing with skin prick tests
(SPT) was done at 7-8 years of age. The test was carried
out according to the standards of the subcommittee on
skin tests of the European Academy of Allergy and Clinical
Immunology [13].Th eall e r g e ne x tract su s edw e r eallo fA L K
m a k e( A L K ,H ø r s h o l m ,D e n m a r k ) ;S o l u p r i c kS Q1 0H E P :
birch, timothy, dog, cat, horse, Dermatophagoides pteronyssi-
nus, and Dermatophagoides farinae. Cladosporium herbarum
was represented by Soluprick in dilution 1:20. Positive
control was histamine 10mg/mL Soluprick. A positive SPT
corresponds to a weal with a diameter exceeding the negative
control (NaCl 9mg/mL) by at least 3mm. A subject was
consideredatopicifhe/shehadatleastonepositiveskinprick
test.
2.3. Phenotyping. We used the combined results from the
original cross-sectional study in 1991, and the two follow-
up studies in 1996 and 2005, to identify asthma phenotypes.
359 subjects could be classiﬁed into one healthy group and
two diﬀerent asthma phenotypes (Table 1).
2.4. Genotyping. The selection of markers and the genotyp-
ing procedure, for single-nucleotide polymorphisms (SNPs)
in the IL4R (interleukine-4 receptor) gene has previously
been described by us [9, 10, 14]. In short, plasma and
buﬀy coat were separated from EDTA-treated venous blood
samples. The buﬀy coats were stored at −70◦C until
DNA extraction. The DNA samples for genotyping were
extracted from buﬀy coats, using the salting out method.
The selected markers (rs2057768, rs2107356, rs3024632,
rs1805010, rs1805015, and rs1801275) represent diﬀerent
linkagedisequilibriumblocksalongtheIL4Rgene(Figure 2),
and they were all tested for possible associations with speciﬁc
asthma phenotypes in our study as deﬁned in Table 1.
2.5. Statistics. Statistical analyses were performed with the
SPSS ver. 15.0.1.1 software (SPSS, Chicago, IL, USA). Dif-
ferences between groups were analysed with exact tests, and
a multiple logistic regression model was used in the analysis
of a potential relationship between early onset asthma and
paternal asthma in order to adjust for a history of eczema in
preschool years. The use of this model could be questioned
since it includes two independent variables, despite the fact
that there are only 11 cases with early onset asthma. We have,
however, decided to present the results from the analysis
since the Hosmer and Lemeshow Test showed an acceptable
Goodness of Fit (P = 0.640).
Cross-tabulations using Monte Carlo simulation tests
with 100,000 iterations were used to compare proportions
between genotype and asthma phenotypes. The signiﬁcance
level was set to 5%.
2.6. Ethics. The study was approved by the Human Research
Ethics Committee of the Medical Faculty, University of
Gothenburg, Sweden.
3. Results
With the combined results from the followup at 12-13 and at
20-21 years of age, 359 of the original 412 children could be
classiﬁed into early onset and late onset asthma phenotypes,
as deﬁned in Table 1. Three inherent risk factors for asthma
(gender, a maternal and a paternal history of asthma), threeJournal of Allergy 3
Questionnaire study 1991
Gothenburg and Kiruna
Stratiﬁed and weighted subsample 1992
Gothenburg and Kiruna, 
Interview and skin prick tests
Followup of stratiﬁed and weighted subsample 1996
Gothenburg and Kiruna, 
Questionnaire, interview, skin prick tests, 
blood sampling, genetic testing, and 
milieu analyses of home environment 
Followup of stratiﬁed and weighted subsample 2005
Questionnaire
n = 2481, years 7–9
n = 412, years 7-8
n = 402, years 12-13
Gothenburg and Kiruna, n = 284, years 21-22
Figure 1: Flow-chart of study design and followup.
Table 1: Deﬁnitions and distributions of asthma phenotypes.
Phenotypes (n = 359) Onset ≤3 Years Onset >3 years Asthma at 7 years Asthma at 13 and/or 21 years
Healthy = no asthma (NA) (n = 318, 89%) No No No No
Early onset asthma (EOA) (n = 11, 3.1%) Yes — — Yes
Late onset asthma (LOA) (n = 30, 8.4%) No Yes — Yes
asthma-associated features (eczema during preschool years,
sensitisation by the age of 7 years, and susceptibility to respi-
ratory infections during the ﬁrst yearof life),and six markers
for single-nucleotide polymorphisms of the IL-4 receptor,
were analysed in respect to these asthma phenotypes.
Ofthethreeinheritedriskfactors,thegenderdistribution
was equal in the group with early onset asthma, whereas a
female predominance was noticed in the late onset asthma
group (Table 2). A maternal history of asthma was a risk
factor for both asthma phenotypes, whereas a paternal
history of asthma was only a risk factor for early onset
asthma. The predominance of a paternal history of asthma
in subjects with early onset asthma may, at least partly, be
explained by the susceptibility to eczema associated with
early onset asthma, as shown in Table 2.I nc o n t r a s tt oa
maternal history of asthma (OR 1.52, 95% CI 0.72–3.20), a
paternal history of asthma was a risk factor for eczema in
the oﬀspring (OR 8.0, 95% CI 1.87–33.9). When adjusting
for “a history of eczema during the child’s ﬁrst 7 years of
life” in a multiple logistic regression model, the association
expressed as OR between a paternal history of asthma and
early onset asthma in the oﬀspring was reduced, but not
completely eliminated (OR 5.3, CI 1.16–24.6).
Sensitisation to inhaled allergens was common in both
early onset and late onset asthma, that is, 2-3 times as
common as in subjects without asthma (Table 2).
Of the six markers for single-nucleotide polymorphisms
in the IL-4-receptor gene, three showed signiﬁcant associa-
tions with the asthma phenotypes tested (Table 3). The AA
genotype of the rs2057768 marker and the GG genotype
of the rs1805010 marker were more commonly seen in late
onset asthma, whereas the GG genotype of the rs2107356
marker was less common in early onset asthma.
4. Discussion
In this follow-up study of children from 7-8 years of age to
young adulthood, we have subgrouped the subjects in the
cohort into two asthma phenotype groups, separated by the
age of onset of asthma, and one group without asthma. The
two asthma phenotype groups were deﬁned to be as similar
as possible to the ones used in the Tucson cohort [8]. Even
though there are similarities between the asthma phenotype
groups, that is, they both represent persistent asthma
and they are both associated with atopy, there were also






































































































Figure 2: Linkage disequilibrium structure in the IL4R locus in
the study population. Numbers correspond to r-square values
calculated in Haploview.
were more prone to recurrent infections and eczema during
early childhood, as compared to children with late onset
asthma, whereas the latter phenotypic group had a female
predominance. We also found genotypic diﬀerences between
the two phenotypes, except from the gender diﬀerence, in
whichtheAAgenotypeofrs2057768andtheGGgenotypeof
rs1805010 were more frequent in late onset asthma, whereas
the GG genotype of rs2107356 was less common in early
onset asthma.
These diﬀerences indicate that early onset asthma and
late onset asthma, despite some phenotypic similarities, may
be diﬀerent endotypes and genotypes.
The susceptibility to develop early childhood eczema
seems to be one pathological pathway separating the two
phenotypes. This diﬀerence in eczema prevalence between
the two subtypes not only was found in reported symptoms
of eczema, but also was supported by hereditary diﬀerences.
In this cohort, a paternal history of asthma increased the
risk of eczema in the oﬀspring, and we have previously
shown that the AA genotype of rs2057768 is less common
in children with eczema [9]. The susceptibility to respiratory
infections during infancy may be a second endotypic or
pathologicaldiﬀerencebetweenthephenotypes.Thisﬁnding
could be explained by the fact that children with early onset
asthma already had developed asthma during the infancy
period, and that common colds therefore cause more severe
symptoms than in nonasthmatic children, symptoms that
are easier to recall by the parents. But it may also be
suggested that this tendency to develop early onset asthma,
early eczema, and a concomitant susceptibility to respiratory
infections during infancy, which are all manifestations or
consequences of an immunological disturbance, is not seen
to the same extent among children who later on develop
late onset asthma. Such an explanation may be supported by
Table 2: Child-associated risk factors for asthma in relation to
asthma phenotypes, as compared to subjects with no asthma.
Variable NA1 n (%) EOA2 n (%) LOA3 n (%)
Gender
Female 141 (44.3) 6 (54.5) 25 (83.3)
Male 177 (55.6) 5 (55.5) 5 (16.7)
P value4 0.549 <0.001
P value5 <0.001
Mother with a history
of asthma
No 289 (93.0) 7 (70.0) 24 (82.8)
Yes 22 (7.0) 3 (30.0) 5 (17.2)
P value4 0.035 0.067
P value5 0.016
Father with a history
of asthma
No 287 (94.7) 7 (70.0) 27 (96.4)
Yes 16 (5.3) 3 (30.0) 1 (3.6)
P value4 0.017 1.000
P value5 0.020
A history of eczema
during the ﬁrst 7
years of age
No 213 (68.1) 2 (18.2) 20 (66.7)
Yes 100 (31.9) 9 (81.8) 10 (33.3)
P value4 0.001 0.877
P value5 0.003
Sensitisation by 7 years
of age
No 235 (77.8) 4 (36.4) 14 (53.8)
Yes 67 (22.2) 7 (63.6) 12 (46.2)
P value4 0.005 0.014
P value5 <0.001
Number of colds during
the ﬁrst year of life
≤5 265 (92.7) 5 (50.0) 21 (87.5)
>5 21 (7.3) 5 (50.0) 3 (12.5)
P value4 0.001 0.414
P value5 <0.001
1No asthma, 2early onset asthma, 3late onset asthma.
4As compared to no asthma, P value based on chi-square, or Fisher’s Exact
Test.
5Between groups, P value based on Exact Test.
the observation that infants with bronchiolitis tend to have
a longer duration of disease, if they also have eczema [15],
and a reduced interferon gamma production by antigen-
stimulated cord blood mononuclear cells is seen in children
who later on develop allergic disorders [16].
The pattern of risk factors found in our study is in
concordance with the results from the original Tucson study
by Martinez and coworkers [8], supporting the assumption
that early onset asthma and late onset asthma might belong
to diﬀerent asthma phenotypes. As in the Tucson study, weJournal of Allergy 5
Table 3: IL-4 receptor polymorphisms and asthma phenotypes.
IL-4 receptor marker NA1 n (%) EOA2 n (%) LOA3 n (%)
rs2057768
AA 14 (7.2) 0 (0.0) 5 (33.3)
AG 74 (38.3) 2 (40.0) 5 (33.3)
GG 105 (54.5) 3 (60.0) 5 (33.3)
P value4 1.0 0.006
P value5 0.018
rs2107356
AA 38 (18.4) 1 (20.0) 1 (6.3)
AG 115 (55.6) 4 (80.0) 6 (37.5)
GG 54 (26.0) 0 (0.0) 9 (56.2)
P value4 0.001 0.414
P value5 <0.001
rs3024632
CC 0 (0.0) 0 (0.0) 0 (0.0)
CT 23 (11.2) 1 (20.0) 1 (6.7)
TT 182 (88.8) 4 (80.0) 14 (93.3)
P value4 1.000 0.711
P value5 0.897
rs1805010
AA 85 (38.1) 2 (33.3) 3 (18.7)
AG 117 (52.5) 4 (66.7) 6 (37.5)
GG 21 (9.4) 0 (0.0) 7 (43.8)
P value4 0.715 0.001
P value5 0.003
rs1805015
AA 157 (70.8) 3 (50.0) 16 (94.1)
AG 56 (25.2) 3 (50.0) 1 (5.9)
GG 9 (4.0) 0 (0.0) 0 (0.0)
P value4 0.487 0.093
P value5 0.138
rs1801275
CC 11 (4.9) 0 (0.0) 0 (0.0)
CT 78 (35.1) 3 (50.0) 5 (27.8)
TT 133 (60.0) 3 (50.0) 13 (72.2)
P value4 0.756 0.461
P value5 0.688
1No asthma, 2early onset asthma, 3late onset asthma.
4As compared to no asthma, P value based on Monte Carlo Tests with
100000 iterations for 3 ×2 tables, and Exact Tests for 2 ×2t a b l e s .
5Between all groups, P value based on Monte Carlo Test, with 100000
iterations.
found that both early and late onset asthma were associated
with atopy and a history of maternal asthma, but only early
onset asthma showed a close association with eczema. Even
though the pattern of risk factors may indicate endotypic
diﬀerences between the two phenotypes, the polymorphic
diﬀerences found in the IL-4 receptor are a further support
for such an assumption. We have previously reported, from
the same cohort, that the AA genotype of rs2057768 was
less common in children with asthma and concomitant
eczema, as compared to those with an asthma phenotype
not associated with eczema [9]. Since this ﬁnding seemed to
be in contrast to results reported byHyt¨ onen and coworkers,
who found that adult female patients with the A allele had
more symptoms of active asthma [10], we concluded in our
previous study that “severe atopic asthma in adult females
may not necessarily be the same phenotype as childhood
asthma with eczema” [9]. In this followup of the same
cohort, with more speciﬁc asthma phenotypes deﬁned, we
can conclude that the assumption we then made seems to be
correct; asthma with eczema in childhood is likely not the
same phenotype as severe atopic asthma in adult females.
Asthma with eczema in children is mainly seen in early onset
asthma, whereas there is a clear female predominance in late
onset asthma. Consequently, the A rs2057768 allele seems to
indicate diﬀerent biological consequences for diﬀerent types
of asthma.
The markers rs2107356 and rs1805010 have previously
been studied in adults with asthma, and the G alleles from
these two markers were found to be more common in adult
femaleswithasthma[17].Inconcordancewiththatstudy,we
found a tendency for a G allele predominance in the female-
dominated late onset asthma in our cohort. The signiﬁcance
of the low GG genotype frequency for rs2107356 seen in
early onset asthma could, however, only be speculated on,
since rs2107356, to our knowledge, has not been studied in
relation to this speciﬁc asthma phenotype before.
How these genetic variants of the IL-4 receptor aﬀect the
disease characteristics of asthma is not known, but it might
be linked to immune modulatory pathways. IL-4 is a proin-
ﬂammatory cytokine stimulating IgE-antibody production
and Th2-lymphocyte diﬀerentiation, and hence promoting
asthma and allergy. These proinﬂammatory eﬀects of IL-4
could, however, be downregulated by soluble IL-4 receptors,
and soluble IL-4 receptors have been used to treat asthma
[18, 19]. In one of the markers in our study (rs1805010),
the GG genotype was in association with lower levels of
soluble IL-4 receptors, as compared to both the AA and
the AG genotypes (Hesselmar, unpublished data) possibly
explaining why this genotype is more common among adult
females with asthma [17] and late onset asthma.
Even though our ﬁndings support the accuracy of
the Tucson-based classiﬁcation system, separating persistent
asthma into two diﬀerent phenotypes depending on age
of onset, our speculations on endotypic and genotypic
diﬀerences between early onset and late onset asthma should
be interpreted with caution. The analyses are based on a
relatively small cohort of children and there is consequently
quite a high risk of type II errors; true diﬀerences are
not detected with statistical signiﬁcance as the criterion.
Additional diﬀerences between the groups, than those
discussed, may exist. A particularly misleading reasoning
appears if diﬀerences that come out as statistically signiﬁcant
are concluded to be larger than those that do not. This
is an invalid interpretation. Furthermore, the retrospective
collection of data covering the preschool period is a further
limitation of the study giving opportunities for recall bias,
and one may criticise the validity of the diagnosis of asthma6 Journal of Allergy
since it was based on questionnaire replies only. However,
we do believe that the questions about asthma used in
the questionnaire have a high speciﬁcity for a diagnosis of
asthma,sincepreviousvalidationinterviewsat12-13yearsof
age revealed that all children giving a positive answer to the
question on current asthma used asthma medications, that
is, inhaled β2-agonists and/or inhaled anti-inﬂammatory
drugs [20]. We should also admit that due to expansion of
known genetic risk factors in the development of asthma
phenotypes, the heterogeneity of children’s and adult asthma
should be reexamined in well-constructed cohorts.
With these cautions in mind, our speculations about
endotypic and genetic diﬀerences between the two asthma
phenotypes should be considered as hypothesis generating, a
hypothesis that needs to be tested in further studies.
5. Conclusions
We found that the asthma phenotypes “early onset asthma”
and “late onset asthma” diﬀer in several characteristics,
suggesting that they may be of diﬀerent endotypes and
genotypes. Consequently, these two asthma phenotypes
might be considered as two diﬀerent disease entities in future
studies on primary prevention of asthma and allergy.
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